These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 11701465)

  • 1. Inclusion of the E3 region in an adenoviral vector decreases inflammation and neointima formation after arterial gene transfer.
    Wen S; Driscoll RM; Schneider DB; Dichek DA
    Arterioscler Thromb Vasc Biol; 2001 Nov; 21(11):1777-82. PubMed ID: 11701465
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adventitial delivery minimizes the proinflammatory effects of adenoviral vectors.
    Schneider DB; Sassani AB; Vassalli G; Driscoll RM; Dichek DA
    J Vasc Surg; 1999 Mar; 29(3):543-50. PubMed ID: 10069919
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improved vascular gene transfer with a helper-dependent adenoviral vector.
    Wen S; Graf S; Massey PG; Dichek DA
    Circulation; 2004 Sep; 110(11):1484-91. PubMed ID: 15326058
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Second-generation adenoviral vectors do not prevent rapid loss of transgene expression and vector DNA from the arterial wall.
    Wen S; Schneider DB; Driscoll RM; Vassalli G; Sassani AB; Dichek DA
    Arterioscler Thromb Vasc Biol; 2000 Jun; 20(6):1452-8. PubMed ID: 10845857
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lung-specific expression of adenovirus E3-14.7K in transgenic mice attenuates adenoviral vector-mediated lung inflammation and enhances transgene expression.
    Harrod KS; Hermiston TW; Trapnell BC; Wold WS; Whitsett JA
    Hum Gene Ther; 1998 Sep; 9(13):1885-98. PubMed ID: 9741427
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stabilization of transgene expression by incorporation of E3 region genes into an adenoviral factor IX vector and by transient anti-CD4 treatment of the host.
    Poller W; Schneider-Rasp S; Liebert U; Merklein F; Thalheimer P; Haack A; Schwaab R; Schmitt C; Brackmann HH
    Gene Ther; 1996 Jun; 3(6):521-30. PubMed ID: 8789802
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generation of recombinant adenovirus vector with infectious adenoviral genome released from cosmid-based vector by simple procedure allowing complex manipulation.
    Kojima H; Ohishi N; Yagi K
    Biochem Biophys Res Commun; 1998 May; 246(3):868-72. PubMed ID: 9618304
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generation and characterization of E1/E2a/E3/E4-deficient adenoviral vectors encoding human factor VIII.
    Andrews JL; Kadan MJ; Gorziglia MI; Kaleko M; Connelly S
    Mol Ther; 2001 Mar; 3(3):329-36. PubMed ID: 11273775
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insertion of the adenoviral E3 region into a recombinant viral vector prevents antiviral humoral and cellular immune responses and permits long-term gene expression.
    Ilan Y; Droguett G; Chowdhury NR; Li Y; Sengupta K; Thummala NR; Davidson A; Chowdhury JR; Horwitz MS
    Proc Natl Acad Sci U S A; 1997 Mar; 94(6):2587-92. PubMed ID: 9122239
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improved adenoviral vector for vascular gene therapy : beneficial effects on vascular function and inflammation.
    Qian HS; Channon K; Neplioueva V; Wang Q; Finer M; Tsui L; George SE; McArthur J
    Circ Res; 2001 May; 88(9):911-7. PubMed ID: 11349000
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of adenovirus-mediated gene transfer in rabbit flexor tendons.
    Mehta V; Kang Q; Luo J; He TC; Haydon RC; Mass DP
    J Hand Surg Am; 2005 Jan; 30(1):136-41. PubMed ID: 15680569
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An adenovirus type 5 (Ad5) amplicon-based packaging cell line for production of high-capacity helper-independent deltaE1-E2-E3-E4 Ad5 vectors.
    Catalucci D; Sporeno E; Cirillo A; Ciliberto G; Nicosia A; Colloca S
    J Virol; 2005 May; 79(10):6400-9. PubMed ID: 15858023
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimizing cardiovascular gene therapy: increased vascular gene transfer with modified adenoviral vectors.
    Kibbe MR; Murdock A; Wickham T; Lizonova A; Kovesdi I; Nie S; Shears L; Billiar TR; Tzeng E
    Arch Surg; 2000 Feb; 135(2):191-7. PubMed ID: 10668880
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of malignant gliomas with a replicating adenoviral vector expressing herpes simplex virus-thymidine kinase.
    Nanda D; Vogels R; Havenga M; Avezaat CJ; Bout A; Smitt PS
    Cancer Res; 2001 Dec; 61(24):8743-50. PubMed ID: 11751394
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Established immunity precludes adenovirus-mediated gene transfer in rat carotid arteries. Potential for immunosuppression and vector engineering to overcome barriers of immunity.
    Schulick AH; Vassalli G; Dunn PF; Dong G; Rade JJ; Zamarron C; Dichek DA
    J Clin Invest; 1997 Jan; 99(2):209-19. PubMed ID: 9005989
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Constitutive expression of the adenovirus E3-14.7K protein does not prolong adenovirus vector DNA persistence but protects mice against lipopolysaccharide-induced acute hepatitis.
    Gantzer M; Spitz E; Accard N; Rooke R
    Hum Gene Ther; 2002 May; 13(8):921-33. PubMed ID: 12031125
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Arterial gene transfer to rabbit endothelial and smooth muscle cells using percutaneous delivery of an adenoviral vector.
    Steg PG; Feldman LJ; Scoazec JY; Tahlil O; Barry JJ; Boulechfar S; Ragot T; Isner JM; Perricaudet M
    Circulation; 1994 Oct; 90(4):1648-56. PubMed ID: 7923648
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduced toxicity, attenuated immunogenicity and efficient mediation of human p53 gene expression in vivo by an adenovirus vector with deleted E1-E3 and inactivated E4 by GAL4-TATA promoter replacement.
    Ji L; Bouvet M; Price RE; Roth JA; Fang B
    Gene Ther; 1999 Mar; 6(3):393-402. PubMed ID: 10435089
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improvements in gene therapy: averting the immune response to adenoviral vectors.
    Ritter T; Lehmann M; Volk HD
    BioDrugs; 2002; 16(1):3-10. PubMed ID: 11908997
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The constitutive expression of the immunomodulatory gp19k protein in E1-, E3- adenoviral vectors strongly reduces the host cytotoxic T cell response against the vector.
    Lee MG; Abina MA; Haddada H; Perricaudet M
    Gene Ther; 1995 Jun; 2(4):256-62. PubMed ID: 7552985
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.